Comorbidity is poor predictor of survival in patients undergoing radical prostatectomy after 70 years of age

Urology

Volumn 68, Issue 3, 2006, Pages 583-586

  Froehner, Michael ^a   Koch, Rainer ^a   Litz, Rainer J ^a   Hakenberg, Oliver W ^a   Oehlschlaeger, Sven ^a   Wirth, Manfred P ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANGINA PECTORIS; ARTICLE; COMORBIDITY; DISEASE CLASSIFICATION; FOLLOW UP; HEART FAILURE; HUMAN; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MANTEL HAENSZEL TEST; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSTATECTOMY; STRATIFICATION; SURVIVAL; TIME SERIES ANALYSIS;

AGE FACTORS; AGED; HUMANS; MALE; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 33748945356     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.03.050     Document Type: Article

References (17)

1. Sim H.G., and Cheng C.W. Changing demography of prostate cancer in Asia. Eur J Cancer 41 (2005) 834-845
2. Grönberg H. Prostate cancer epidemiology. Lancet 361 (2003) 859-864
3. Lepor H. Selecting candidates for radical prostatectomy. Rev Urol 2 (2000) 182-189
4. Schwartz K.L., Alibhai S.M.H., Tomlinson G., et al. Continued undertreatment of older men with localized prostate cancer. Urology 62 (2003) 860-865
5. Parker C. Active surveillance: towards a new paradigm in the management of early prostate cancer. Lancet Oncol 5 (2004) 101-106
6. Khan M.A., Partin A.W., and Carter H.B. Expectant management of localized prostate cancer. Urology 62 (2003) 793-799
7. Bill-Axelson A., Holmberg L., Ruutu M., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352 (2005) 1977-1984
8. Alibhai S.M.H., Naglie G., Nam R., et al. Do older men benefit from curative therapy of localized prostate cancer?. J Clin Oncol 21 (2003) 3318-3327
9. Barry M.J., Albertsen P.C., Bagshaw M.A., et al. Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostatectomy, external beam radiotherapy, or expectant management: a retrospective analysis. Cancer 91 (2001) 2302-2314
10. Sweat S.D., Bergstralh E.J., Slezak J., et al. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. J Urol 168 (2002) 525-529
11. Hall W.H., Jani A.B., Ryu J.K., et al. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer. Prostate Cancer Prostatic Dis 8 (2005) 22-30
12. Post P.N., Hansen B.E., Kil P.J.M., et al. The independent prognostic value of comorbidity among men aged <75 years with localized prostate cancer: a population-based study. BJU Int 87 (2001) 821-826
13. Froehner M., Koch R., Litz R.J., et al. Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomy. Eur Urol 47 (2005) 190-195
14. Froehner M., Koch R., Litz R., et al. Comparison of the American Society of Anesthesiologists Physical Status classification with the Charlson score as predictors of survival after radical prostatectomy. Urology 62 (2003) 698-701
15. Froehner M., Koch R., Litz R.J., et al. Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomy. Scand J Urol Nephrol 39 (2005) 449-454
16. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40 (1987) 373-383
17. Eapen L., Villeneuve P.J., Levy I.G., et al. Comorbid survival among elderly participants of the Canada Health Survey: relevance to prostate cancer screening and treatment. Chronic Dis Can 19 (1998) 84-90